Understanding and Treating Legionnaires’ Disease: A Clinical Case Study
Introduction
Legionnaires’ disease is a serious infection caused primarily by the bacterium Legionella pneumophila. It typically presents with pneumonia-like symptoms and can also affect multiple organs outside the lungs. This condition accounts for approximately 4.6% of community-acquired pneumonia cases and can lead to severe complications, including multi-organ failure. As a result, early diagnosis and prompt, targeted treatment are crucial to improving outcomes and reducing mortality rates. However, the non-specific nature of clinical symptoms and difficulties in obtaining accurate laboratory evidence often lead to delayed or missed diagnoses.
Case Presentation
An 81-year-old male patient was admitted to Huizhou Central People’s Hospital on September 18, 2022, with complaints of fever and shortness of breath. The patient had developed a fever three days prior, with a maximum temperature of 39.5°C, and also experienced symptoms such as chills, fatigue, muscle pain, intermittent cough, and minimal sputum production. Despite self-medicating with oral antibiotics and pain relievers, the fever remained, prompting a visit to the emergency department. A chest CT scan revealed significant consolidation in the left lung, patchy exudative lesions in the right lung, and a small amount of pleural effusion in the left lung (Figure 1A–C).
Upon arrival, the patient was found to have a moderate fever (39.1°C), rapid breathing (30 breaths/min), and high pulse rate (95 beats/min). Despite receiving an antibiotic regimen of piperacillin-sulbactam, the fever persisted, and he was subsequently admitted to the hospital. The patient had a five-year history of uncontrolled type 2 diabetes mellitus.
Physical examination also revealed coarse breath sounds in both lungs, particularly wet rales in the left lower lung. Laboratory tests showed abnormal results, including elevated ferritin levels (>2000 μg/L), hypophosphatemia (1.52 mmol/L), and microscopic hematuria (530/μL). These findings, along with the clinical presentation and imaging results, raised suspicion of Legionnaires’ disease.
Discussion
Legionella bacteria are commonly found in water distribution systems and soil, particularly in cooling towers and air conditioning condensate. Inhalation of aerosolized Legionella can lead to pneumonia and extrapulmonary infections. Risk factors for Legionnaires’ disease include advanced age, male sex, a history of smoking, immunodeficiency, and chronic lung disease. Once Legionella enters the body through the respiratory tract, it proliferates within alveolar macrophages before spreading to other parts of the body, causing systemic infections with pulmonary involvement and multiple organ dysfunction.
The rapid progression of the patient’s symptoms, including the development of respiratory failure along with changes in liver and kidney function, suggested Legionnaires’ disease. This case highlights the importance of considering Legionnaires’ disease in patients with community-acquired pneumonia who present with multi-organ involvement. Key clinical and imaging features that can indicate Legionnaires’ disease include elevated body temperature, a slow pulse rate, high erythrocyte sedimentation rate or C-reactive protein levels, increased ferritin, hypophosphatemia, elevated creatine kinase, and hematuria.
Diagnosis of Legionnaires’ disease typically relies on microbial culture, urinary antigen testing, PCR, and antibody testing. However, these methods can be time-consuming, have limited sensitivity, and may miss cases. A newer approach, metagenomic next-generation sequencing (mNGS), has emerged as a powerful diagnostic tool. This technique allows for rapid and unbiased detection of a wide range of pathogens directly from clinical samples, facilitating early identification of Legionnaires’ disease.
Once diagnosed, treatment for Legionnaires’ disease often involves antibiotics that can effectively penetrate tissues and intracellular compartments where Legionella resides. Fluoroquinolones, macrolides, and tetracyclines are commonly prescribed. However, in cases with severe organ dysfunction, these drugs may not be suitable. In our case, the patient was treated with omadacycline, a novel aminomethylcycline. This antibiotic demonstrates excellent activity against Legionella, has a broad spectrum, and is less prone to resistance. Additionally, it maintains its effectiveness in patients with compromised liver and kidney function, making it an ideal treatment option for severe Legionnaires’ disease.
While addressing this case, it is crucial to note that if Legionnaires’ disease is suspected, routine testing for Legionella antibodies in urine is advisable. However, this was not possible in our setting due to the absence of the necessary diagnostic equipment.
Conclusion
Legionnaires’ disease is a severe and potentially life-threatening condition that can lead to significant morbidity and mortality. Early diagnosis, followed by targeted antibiotic therapy, is essential for improving outcomes. This case study underscores the importance of considering Legionnaires’ disease in patients presenting with unexplained pneumonia and multi-organ involvement. Metagenomic next-generation sequencing provides a promising diagnostic tool, while novel antibiotics like omadacycline offer effective treatment options, especially in patients with severe organ dysfunction.
Data Sharing Statement
Ethics Approval and Informed Consent
The study received approval from the Ethics Committees of Huizhou Central People’s Hospital. Informed consent was obtained from the patient for publication of this case study.
Consent for Publication
The patient provided written consent to publish the case details.
Funding
No funding was received for this study.
Disclosure
The authors have no conflicts of interest to declare.
